Fasenra (benralizumab): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

Fasenra 30 mg solution for injection in pre filled syringe

Fasenra is indicated as an add-on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long-acting β-agonists.


Route of administration: Injectable
Molecule: benralizumab

Patients' opinions on Fasenra

In brief

General satisfaction level: 7.00/10 Learn more

Treatment's effectiveness: Be the first to evaluate

Ease of use: 9.00/10 Learn more

Adherence to prescription: 10.00/10 Learn more

Detected side effects: 4.00/10 Learn more

Improvement in the quality of life: 6.00/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community


avatar
Dulux1963
on 25/04/2026

I am advised that the first 3 months are the loading faze and I should start to feel better after injection 4

Your message

Conditions related to this medication

Fact sheet

Asthma

See the fact sheet